ArticleBMC microbiology2025
Whole-genome sequencing and probiotic properties of Lactobacillus helveticus KM7 isolated from the gut of the Chinese honey bee (Apis cerana): A promising exopolysaccharide-producing strain.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Functional, Modeling and Antimicrobial Characterization of Lactobacillus helveticus BGRA43 Isolated from Traditional Iranian Cheese.Probiotics and antimicrobial proteins · 2026Article
- Phenotypic, Genomic, and In Vivo Characterization of a Host-Derived Limosilactobacillus fermentum RLF77 with Potential to Prevent Post-weaning Diarrhea in Rabbits.Probiotics and antimicrobial proteins · 2026Article
- Draft genome sequence of potential probioticMicrobiology resource announcements · 2026Article
- The Wine Ecosystem as a Reservoir for Potential Probiotics: A Comparative In Vitro Evaluation ofFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Lactobacillus helveticus is a probiotic bacterium widely used in the food industry. In this study, we evaluate the safety and probiotic properties of L. helveticus strain KM7, isolated from the gut of Apis cerana, through whole-genome sequencing and in vitro experiments. The complete genome consists of 2,164,024 bp, encoding 2192 genes with an average GC content of 36.82%. The strain lacks identifiable virulence factor genes and antibiotic resistance genes, shows no hemolytic activity, and cannot produce biogenic amines such as spermine, cadaverine, or putrescine. L. helveticus KM7 exhibited strong acid and bile salt tolerance, superior adhesion capacity, and remarkable antioxidant activity, with its genome harboring genes associated with these traits. It contains gene clusters potentially involved in the biosynthesis of bacteriocins Helveticin J and Enterolysin A, as well as encoding multiple genes of carbohydrate-active enzymes. Moreover, KM7 demonstrated excellent exopolysaccharide-producing capability, and glucose supplementation in the medium enhanced yield. These findings indicate that KM7 is a safe strain with promising probiotic properties, highlighting its potential for food applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.